GlaxoSmithKline plc (GSK) |
|
43.08 0.32 (0.75%)
|
02-21 16:02 |
|
Open: |
42.82 |
Pre. Close: |
42.76 |
|
High:
|
43.2 |
Low:
|
42.76 |
|
Volume:
|
3,832,924 |
Market Cap:
|
107787M |
|
|
|
|
GlaxoSmithKline PLC creates, discovers, develops, manufactures and markets pharmaceutical products including respiratory and antiviral, vaccines, over-the-counter (OTC) medicines and health-related consumer products. |
Stock Price Prediction |
Update at 5:00pm EST |
|
If tomorrow:
|
Open lower
|
Open higher
|
|
High:
|
43.301 - 43.587 |
43.587 - 43.847 |
|
Low:
|
42.039 - 42.411 |
42.411 - 42.747 |
|
Close:
|
42.511 - 43.091 |
43.091 - 43.615 |
|
Technical analysis |
as of: 2020-02-21 4:30:37 PM |
|
Overall:
|
  |
| Stoxline posted a NEUTRAL today, upgraded from lower rating. Current trend continues, but could change at anytime. It is not a good time to buy or sell. |
| Target: |
Six months: 53.79 One year: 56.36 |
| Support: |
Support1: 42.51 Support2: 35.37 |
| Resistance: |
Resistance1: 46.06 Resistance2: 48.25 |
| Pivot: |
44.50  |
| Moving Average: |
MA(5): 43.32 MA(20): 45.11
MA(100): 44.99 MA(250): 42.38 |
| MACD: |
MACD(12,26): -0.94 Signal(9): -0.71 |
| Stochastic oscillator: |
%K(14,3): 7.12 %D(3): 6.07 |
| RSI: |
RSI(14): 30.31 |
| 52-week: |
High: 48.25 Low: 38.43 Change(%): 6.4 |
| Average Vol(K): |
3-Month: 308735 10-Days: 373804 |
|
Price, moving averages and Bollinger Bands |
|
Price and moving averages has closed below its Short term moving average. Short term moving average is currently below mid-term; AND below long term moving averages. From the relationship between price and moving averages; we can see that: This stock is BEARISH in short-term; and NEUTRAL in mid-long term.GSK has closed above bottom band by 23.1%. Bollinger Bands are 106.5% wider than normal. The large width of the bands suggest high volatility as compared to GSK's normal range. The bands have been in this wide range for 10 bars. This is a sign that the current trend might continue. |
|
|
Headline News |
Sun, 23 Feb 2020 12:07:00 +0000
Better Buy: GlaxoSmithKline vs. Eli Lilly
Fri, 21 Feb 2020 21:42:00 +0000
FDA's Advisory Committee to Review Claims That GlaxoSmithKline's Trelegy Ellipta Reduces Mortality
Fri, 21 Feb 2020 18:55:00 +0000
A Plan to Use Blockchain to Stop Counterfeit Drugs Moves Forward
Fri, 21 Feb 2020 02:25:00 +0000
Merck's Chief Digital Officer Leaves to Join Marriott
Fri, 21 Feb 2020 02:25:00 +0000
Merck's Chief Digital Officer Leaves to Join Marriott
|
Financial Analysis |
| Growth |
 |
| Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing. |
| Profitability |
|
| Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs. |
| Solvency |
 |
| Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry. |
| Efficiency |
|
| Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not. |
| Click here to get more fundamental analysis.
|
|
|
|
